Last Wednesday the stock of Soligenix Inc (OTCBB:SNGX) suddenly crashed hard registering a loss of more than 17%. On the next day things got even worse – in a single session the company saw 38%...
Unlike an alarmingly large number of its OTC counterparts, Soligenix Inc (OTCBB:SNGX) isn’t just a one-week promo-induced flash in the pan. Far from it, in fact. The stock was actually once listed on the...
Yesterday Vista Partners LLC decided to reiterate that they have given the stock of Soligenix Inc (OTCBB:SNGX) a twelve-month price target of $7. Vista had given SNGX a price target of $5.5 per share...
Here’s something you don’t see every day in Pennyland. If you take a look at the chart on the right, you’ll notice that Soligenix Inc (OTCBB:SNGX) has actually proven itself to be quite a...
Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) is continuing its odd behavior, sinking again by more than 16% to stand at $0.453. The ticker was traded on volumes above $866,000. Without a promotion or a PR, BZNE...
After selling a new issue of shares and warrants below market price, International Stem Cell Corp, Inc. (OTCMKTS:ISCO) disappeared from the volumes radar for a while. Now, ISCO is back on a new bunch...
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) really took off on Monday, vaulting over the $1 levels to reach $1.16 on the day, on buying volumes of $3.6 million. The ticker added nearly 24% on the day,...
As the end of 2013 is in sight, Titan Pharmaceuticals, Inc. (OTCBB:TTNP) seems headed to repeating its feat from the end of last year, where after a long stagnant period the ticker exploded and...
When a stock with a market cap a still low $5.9 million, something unusual may be going on. The unusual factor is a big $3.5 million injection from private investors into La Jolla Pharmaceutical,...
For a few months now, Titan Pharmaceuticals, Inc. (OTCBB:TTNP) has been struggling with recovery, but last week came with higher volumes that may require some attention. There are early indicators that the FDA is...